PEDF regulates osteoclasts via osteoprotegerin and RANKL

Toru Akiyama, Crispin R. Dass, Yusuke Shinoda, Hirotaka Kawano, Sakae Tanaka, Peter F.M. Choong

Research output: Contribution to journalArticlepeer-review

71 Scopus citations

Abstract

Bone homeostasis is maintained through a balance between bone formation and resorption. Bone resorption is mainly carried out by a specific type of cell called the osteoclast (OCL). Previously, expression of pigment epithelium-derived factor (PEDF), the most potent endogenous inhibitor of angiogenesis, has been demonstrated in bone tissue and it known to induce differentiation in osteoblastic cells. Furthermore, therapeutic effects of PEDF on osteosarcoma, a prevalent primary bone tumor, with inhibition of bone destruction has been shown. Thus, PEDF is possibly involved in bone homeostasis as an inhibitor of bone resorption. To address this involvement, we studied the effect of PEDF on OCL function. OCL differentiation, RANKL-mediated survival and bone resorption activity were inhibited by PEDF in a dose-dependent manner. PEDF upregulated osteoprotegerin (OPG), which naturally blocks OCL maturation, in primary osteoblasts and OCL precursor cells. These results suggest that PEDF inhibits OCL function via regulating OPG expression, and thereby contributes to the maintenance of bone homeostasis.

Original languageEnglish
Pages (from-to)789-794
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume391
Issue number1
DOIs
StatePublished - 1 Jan 2010
Externally publishedYes

Keywords

  • OPG
  • Osteoclast
  • PEDF
  • RANK
  • RANKL

Fingerprint

Dive into the research topics of 'PEDF regulates osteoclasts via osteoprotegerin and RANKL'. Together they form a unique fingerprint.

Cite this